Pfizer’s shares (currently trading at $26.70) have posted a disappointing 10.2% loss, well below the S&P 500’s 3.8% gain.

Passive income investors looking to get paid to navigate a more turbulent stock market should look to the many dividend ...

We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look ...

Dr. Naomi Wolf spoke at an India Today event about her book 'The Pfizer Papers', which examines internal Pfizer documents on COVID-19 vaccine development. She alleges the company knew of serious side ...

Wolf, who stated that she is not vaccinated against Covid-19, claimed that live birth rates have dropped by 13-20%, ...

The general mood among these heavyweight investors is divided, with 48% leaning bullish and 37% bearish. Among these notable options, 5 are puts, totaling $799,839, and 22 are calls, amounting to ...

Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

In a report released today, Kerry Holford from Berenberg Bank maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...

The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.